Table 2.
Odds Ratios (ORs) of Prevalent Frailty by Average Annual NSAID Use Among 12 101 Physicians’ Health Study Participants
| Model | OR of Frail vs Nonfrail* | 95% CI | p-Trend |
|---|---|---|---|
| Frailty determined using frailty index score ≥0.21 | |||
| 0 days/year | Ref | — | <.001 |
| ≤12 days/year | 0.91 | 0.80–1.03 | |
| 13–60 days/year | 1.02 | 0.89–1.17 | |
| >60 days/year | 1.26 | 1.07–1.49 | |
| Frailty determined using mSOF score ≥2 (n = 12 028) | |||
| 0 days/year | Ref | — | <.001 |
| ≤12 days/year | 1.15 | 0.96–1.37 | |
| 13–60 days/year | 1.53 | 1.27–1.85 | |
| >60 days/year | 1.95 | 1.56–2.43 |
Notes: CI = confidence interval; mSOF score = modified Study of Osteoporotic Fracture score; NSAID = nonsteroidal anti-inflammatory drug.
*All models were run after the propensity score weighting was applied.